Cargando…
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials
BACKGROUND: Elevated levels of inflammatory factors are associated with poor prognosis in coronavirus disease-19 (COVID-19). However, mesenchymal stem cells (MSCs) have immunomodulatory functions. Accordingly, this meta-analysis aimed to determine the efficacy and safety of MSC-based therapy in pati...
Autores principales: | Liu, Qinxue, Ma, Fengjie, Zhong, Yizhi, Wang, Gaojian, Hu, Li, Zhang, Yaping, Xie, Junran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159228/ https://www.ncbi.nlm.nih.gov/pubmed/37143167 http://dx.doi.org/10.1186/s13287-023-03286-8 |
Ejemplares similares
-
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
por: Wei, Fengtao, et al.
Publicado: (2021) -
Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia
por: Chu, Meiping, et al.
Publicado: (2022) -
Effects of human umbilical cord-derived mesenchymal stem cells on hematologic malignancies
por: Li, Qian, et al.
Publicado: (2018) -
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
por: Feng, Ying, et al.
Publicado: (2020) -
Umbilical Cord-Derived Mesenchymal Stem Cells for Hematopoietic Stem Cell Transplantation
por: Chao, Yu-Hua, et al.
Publicado: (2012)